File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: COVID‐19 and gynecological cancers: Asia and Oceania Federation of Obstetrics and Gynecology oncology committee opinion

TitleCOVID‐19 and gynecological cancers: Asia and Oceania Federation of Obstetrics and Gynecology oncology committee opinion
Authors
KeywordsAOFOG opinion
COVID-19
gynecological cancer
Issue Date2021
PublisherWiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.wiley.com/WileyCDA/WileyTitle/productCd-JOG.html
Citation
Journal of Obstetrics and Gynaecology Research, 2021, v. 47 n. 5, p. 1643-1650 How to Cite?
AbstractSince the outbreak of COVID-19, there have already been over 26 million people being infected and it is expected that the pandemic will not end in near future. Not only the daily activities and lifestyles of individuals have been affected, the medical practice has also been modified to cope with this emergency catastrophe. In particular, the cancer services have faced an unprecedented challenge. While the services may have been cut by the national authorities or hospitals due to shortage of manpower and resources, the medical need of cancer patients has increased. Cancer patients who are receiving active treatment may develop various kinds of complications especially immunosuppression from chemotherapy, and they and their carers will need additional protection against COVID-19. Besides, there is also evidence that cancer patients are more prone to deteriorate from COVID-19 if they contract the viral infection. Therefore, it is crucial to establish guidelines so that healthcare providers can triage their resources to take care of the most needed patients, reduce less important hospitalization and visit, and to avoid potential complications from treatment. The Asia and Oceania Federation of Obstetrics and Gynecology (AOFOG) hereby issued this opinion statement on the management of gynecological cancer patients during the COVID-19.
DescriptionBronze open access
Persistent Identifierhttp://hdl.handle.net/10722/302125
ISSN
2020 Impact Factor: 1.73
2020 SCImago Journal Rankings: 0.597
PubMed Central ID

 

DC FieldValueLanguage
dc.contributor.authorTse, KY-
dc.contributor.authorDomingo, EJ-
dc.contributor.authorKonar, H-
dc.contributor.authorKumarasamy, S-
dc.contributor.authorPariyar, J-
dc.contributor.authorTjokroprawiro, BA-
dc.contributor.authorUshijima, K-
dc.contributor.authorInthasorn, P-
dc.contributor.authorTan, AL-
dc.contributor.authorWilailak, S-
dc.contributor.authorThe Oncology Committee, Asia and Oceania Federation of Obstetrics and Gynecology,-
dc.date.accessioned2021-08-21T03:31:56Z-
dc.date.available2021-08-21T03:31:56Z-
dc.date.issued2021-
dc.identifier.citationJournal of Obstetrics and Gynaecology Research, 2021, v. 47 n. 5, p. 1643-1650-
dc.identifier.issn1341-8076-
dc.identifier.urihttp://hdl.handle.net/10722/302125-
dc.descriptionBronze open access-
dc.description.abstractSince the outbreak of COVID-19, there have already been over 26 million people being infected and it is expected that the pandemic will not end in near future. Not only the daily activities and lifestyles of individuals have been affected, the medical practice has also been modified to cope with this emergency catastrophe. In particular, the cancer services have faced an unprecedented challenge. While the services may have been cut by the national authorities or hospitals due to shortage of manpower and resources, the medical need of cancer patients has increased. Cancer patients who are receiving active treatment may develop various kinds of complications especially immunosuppression from chemotherapy, and they and their carers will need additional protection against COVID-19. Besides, there is also evidence that cancer patients are more prone to deteriorate from COVID-19 if they contract the viral infection. Therefore, it is crucial to establish guidelines so that healthcare providers can triage their resources to take care of the most needed patients, reduce less important hospitalization and visit, and to avoid potential complications from treatment. The Asia and Oceania Federation of Obstetrics and Gynecology (AOFOG) hereby issued this opinion statement on the management of gynecological cancer patients during the COVID-19.-
dc.languageeng-
dc.publisherWiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.wiley.com/WileyCDA/WileyTitle/productCd-JOG.html-
dc.relation.ispartofJournal of Obstetrics and Gynaecology Research-
dc.rightsSubmitted (preprint) Version This is the pre-peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article using the DOI]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. Accepted (peer-reviewed) Version This is the peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article using the DOI]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.-
dc.subjectAOFOG opinion-
dc.subjectCOVID-19-
dc.subjectgynecological cancer-
dc.titleCOVID‐19 and gynecological cancers: Asia and Oceania Federation of Obstetrics and Gynecology oncology committee opinion-
dc.typeArticle-
dc.identifier.emailTse, KY: tseky@hku.hk-
dc.identifier.authorityTse, KY=rp02391-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1111/jog.14579-
dc.identifier.pmid33650217-
dc.identifier.pmcidPMC8013896-
dc.identifier.scopuseid_2-s2.0-85101815778-
dc.identifier.hkuros324205-
dc.identifier.volume47-
dc.identifier.issue5-
dc.identifier.spage1643-
dc.identifier.epage1650-
dc.publisher.placeAustralia-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats